Osteoporosis After Stroke
Launched by GAZILER PHYSICAL MEDICINE AND REHABILITATION EDUCATION AND RESEARCH HOSPITAL · Jul 1, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how bone strength changes in people who have had a stroke, specifically looking at the differences between the weaker (paralyzed) and stronger limbs. The goal is to understand what factors affect bone health during the weeks and months after a stroke, which could help improve care and prevent bone problems like osteoporosis—a condition where bones become weak and more likely to break.
To join this study, participants need to be between 40 and 65 years old and have had a stroke on one side of the body, confirmed by brain scans (MRI or CT). They should be mentally alert enough to follow study instructions and have stable health. People with other bone or neurological conditions, multiple strokes, or certain diseases that affect bones won’t be able to join. If eligible, participants will be asked to take part in tests that measure bone strength in their limbs. This research is not yet recruiting, but it hopes to provide important information to help stroke patients maintain stronger bones and reduce the risk of fractures in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 40-65 years with a unilateral stroke confirmed by magnetic resonance imaging (MRI) or computed tomography (CT)
- • Patients with a cognitive status sufficient to understand the study instructions (Mini-Mental State Assessment score ≥ 23)
- • Patients with stable medical and psychological status
- • Patients willing to participate in the study
- Exclusion Criteria:
- • Presence of hip pathologies that may lead to incorrect measurements in bone mineral density (advanced osteophytic coxarthrosis, heterotrophic ossification, internal fixator, etc.)
- • Previous hip, lumbar vertebra fractures (osteoporotic compression fractures)
- • History of multiple strokes
- • History of concomitant neurological diseases other than stroke (Parkinson, multiple sclerosis, myopathy, etc.)
- • History of diseases that may cause secondary osteoporosis (hypogonadism, primary hyperparathyroidism, thyrotoxicosis, malabsorption, etc.)
About Gaziler Physical Medicine And Rehabilitation Education And Research Hospital
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital is a leading institution dedicated to advancing the field of rehabilitation through innovative clinical research and education. Committed to enhancing patient care and outcomes, the hospital integrates cutting-edge research with comprehensive rehabilitation programs. By fostering collaboration among healthcare professionals, researchers, and academic institutions, Gaziler Hospital aims to develop evidence-based practices and innovative therapeutic solutions. With a focus on patient-centered care, the hospital strives to improve the quality of life for individuals with physical impairments and disabilities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Engin Koyuncu, Prof.
Study Director
SBÜ ANKARA GAZİLER FİZİK TEDAVİ VE REHABİLİTASYON EĞİTİM VE ARAŞTIRMA HASTANESİ
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported